• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载环丙沙星的纳米结构脂质载体的制备、表征及抗菌性能及其在抗感染治疗中的应用

Preparation, characterisation and antibacterial property of ciprofloxacin-loaded nanostructured lipid carrier for treatment of infection.

机构信息

a Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Drug Delivery and Nanomedicines Research Group , University of Nigeria , Nsukka , Nigeria.

d Department of Drug Delivery , Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Saarland University , Saarbrücken , Germany.

出版信息

J Microencapsul. 2019 Jan;36(1):32-42. doi: 10.1080/02652048.2019.1582724. Epub 2019 Mar 4.

DOI:10.1080/02652048.2019.1582724
PMID:30758259
Abstract

In this study, controlled ciprofloxacin (CIPRO) nanostrustructured lipid carriers of Precirol ATO 5/Transcutol HP (batch A) and tallow fat/Transcutol HP (batch B) was carreid out. Objective: The aim was to improve solubility and bioavailability of CIPRO. Study of controlled ciprofloxacin (CIPRO) nanostructured lipid carriers of Precirol ATO 5/Transcutol HP (batch A) and tallow fat/Transcutol HP (batch B). CIPRO concentrations C (0.0, 0.2, 0.5, 0.8, and 1.0% w/w) as AC and BC were prepared by hot homogenisation and characterised by zetasizer, differential scanning calorimetry, Fourier transform infra-red spectroscopy, drug release and growth inhibitory zone diameter (IZD) on agar-seeded . AC achieved polydispersed particles of ∼605 nm, 92% encapsulation efficiency (EE) and -28 mV similar to BC (∼789 nm, 91% EE, and -31 mV). Crystallinity indices (AC and BC) were low at 3 and 5%, respectively. CIPRO release in AC was ∼98% in SGF (pH 1.2) and BC similarly ∼98% in SIF (pH 6.8). AC had superior growth inhibition of at lower concentration (1.2 µg/mL) than BC and CIPRO controls; hence could serve as possible sustained delivery system of CIPRO.

摘要

本研究制备了载有环丙沙星(CIPRO)的纳米结构脂质载体,载体由 Precirol ATO 5/Transcutol HP(A 批)和牛脂/Transcutol HP(B 批)组成。目的:旨在提高 CIPRO 的溶解度和生物利用度。

研究载有环丙沙星(CIPRO)的纳米结构脂质载体,载体由 Precirol ATO 5/Transcutol HP(A 批)和牛脂/Transcutol HP(B 批)组成。

CIPRO 浓度 C(0.0、0.2、0.5、0.8 和 1.0%w/w)分别作为 AC 和 BC 通过热匀浆法制备,并通过激光粒度仪、差示扫描量热法、傅里叶变换红外光谱、药物释放和琼脂接种的抑菌圈直径(IZD)进行了表征。AC 获得了约 605nm 的多分散性颗粒,92%的包封效率(EE)和-28mV,与 BC(约 789nm,91%EE 和-31mV)相似。结晶度指数(AC 和 BC)分别为 3%和 5%,均较低。AC 在 SGF(pH 1.2)中的 CIPRO 释放约为 98%,BC 则在 SIF(pH 6.8)中同样约为 98%。AC 在较低浓度(1.2μg/mL)下对的生长抑制作用优于 BC 和 CIPRO 对照,因此可能作为 CIPRO 的可持续输送系统。

相似文献

1
Preparation, characterisation and antibacterial property of ciprofloxacin-loaded nanostructured lipid carrier for treatment of infection.载环丙沙星的纳米结构脂质载体的制备、表征及抗菌性能及其在抗感染治疗中的应用
J Microencapsul. 2019 Jan;36(1):32-42. doi: 10.1080/02652048.2019.1582724. Epub 2019 Mar 4.
2
Sustained-release liquisolid compact tablets containing artemether-lumefantrine as alternate-day regimen for malaria treatment to improve patient compliance.含有蒿甲醚-本芴醇的缓释液固复合片作为疟疾治疗的隔日疗法,以提高患者的依从性。
Int J Nanomedicine. 2016 Nov 28;11:6365-6378. doi: 10.2147/IJN.S92755. eCollection 2016.
3
Selection and characterization of suitable lipid excipients for use in the manufacture of didanosine-loaded solid lipid nanoparticles and nanostructured lipid carriers.选择和鉴定适合用于制造载双脱氧胞苷的固体脂质纳米粒和纳米结构脂质载体的脂质辅料。
J Pharm Sci. 2011 Dec;100(12):5185-96. doi: 10.1002/jps.22711. Epub 2011 Jul 24.
4
The use of hot and cold high pressure homogenization to enhance the loading capacity and encapsulation efficiency of nanostructured lipid carriers for the hydrophilic antiretroviral drug, didanosine for potential administration to paediatric patients.利用热高压匀化和冷高压匀化技术来提高亲水性抗逆转录病毒药物,即双脱氧肌苷的纳米结构脂质载体的载药量和包封效率,以便将其用于儿科患者的潜在给药。
Pharm Dev Technol. 2012 May-Jun;17(3):353-62. doi: 10.3109/10837450.2010.542163. Epub 2011 Jan 17.
5
Formulation and delivery of itraconazole to the brain using a nanolipid carrier system.使用纳米脂质载体系统将伊曲康唑制剂递送至脑部。
Int J Nanomedicine. 2014 May 2;9:2117-26. doi: 10.2147/IJN.S57565. eCollection 2014.
6
Implications of formulation design on lipid-based nanostructured carrier system for drug delivery to brain.制剂设计对用于脑部药物递送的脂质基纳米结构载体系统的影响。
Drug Deliv. 2016 May;23(4):1306-16. doi: 10.3109/10717544.2014.943337. Epub 2014 Jul 31.
7
In vitro antibacterial activity of ciprofloxacin loaded chitosan microparticles and their effects on human lung epithelial cells.载环丙沙星壳聚糖微球的体外抗菌活性及其对人肺上皮细胞的影响。
Int J Pharm. 2019 Oct 5;569:118578. doi: 10.1016/j.ijpharm.2019.118578. Epub 2019 Jul 27.
8
Antimicrobial activity and biocompatibility of slow-release hyaluronic acid-antibiotic conjugated particles.缓释透明质酸-抗生素偶联粒子的抗菌活性和生物相容性。
Int J Pharm. 2020 Feb 25;576:119024. doi: 10.1016/j.ijpharm.2020.119024. Epub 2020 Jan 9.
9
Preparation and in vitro evaluation of xanthan gum facilitated superabsorbent polymeric microspheres.黄原胶促进的高吸水性聚合物微球的制备及体外评价。
Carbohydr Polym. 2013 Oct 15;98(1):64-72. doi: 10.1016/j.carbpol.2013.05.011. Epub 2013 May 15.
10
Nanostructured lipid carrier potentiated oral delivery of raloxifene for breast cancer treatment.纳米结构脂质载体增强了雷洛昔芬的口服递送,用于乳腺癌治疗。
Nanotechnology. 2020 Nov 20;31(47):475101. doi: 10.1088/1361-6528/abaf81.

引用本文的文献

1
Development of Inhalable Nanostructured Lipid Carriers for Ciprofloxacin for Noncystic Fibrosis Bronchiectasis Treatment.用于非囊性纤维化支气管扩张症治疗的环丙沙星吸入式纳米结构脂质载体的研制。
Int J Nanomedicine. 2021 Mar 25;16:2405-2417. doi: 10.2147/IJN.S286896. eCollection 2021.